Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus

NCT02098616 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: DCV/ASV/BMS-791325
DRUG: DCV/ASV/BMS-791325 + RBV

Sponsor

Timothy Morgan, MD

Collaborators

[object Object]
[object Object]
[object Object]